| Literature DB >> 9104543 |
D J Borecky1, J J Stephenson, J H Keeling, S J Vukelja.
Abstract
A case of acute myelocytic leukemia of the FAB-M2 subtype in a patient who experienced pigmentary nail changes in conjunction with idarubicin therapy is presented. Although doxorubicin and daunorubicin have been reported to cause nail pigmentation changes, this is the first case report to describe these changes with idarubicin.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9104543
Source DB: PubMed Journal: Cutis ISSN： 0011-4162